Digital Health: Tele-consultation, e-Pharmacy and Care Tech

Overview

Digital health spans e-pharmacy, tele-consultation, diagnostics aggregation, chronic-care management and health records, expanding access beyond metro hospitals. Smartphone penetration, the Ayushman Bharat Digital Mission (ABDM) health-records framework and post-pandemic behaviour shifts have accelerated adoption. e-Pharmacy is the largest and most monetisable vertical today.

Business models blend product commerce (medicine delivery), subscription care and platform commissions, with cross-sell across pharmacy, diagnostics and consultation improving unit economics. Chronic-disease management and insurance tie-ups are emerging as higher-value, stickier segments. Trust, fulfilment reliability and regulatory clarity shape adoption.

The regulatory environment for e-pharmacy and tele-health is still evolving, creating both opportunity and uncertainty. Profitability depends on repeat usage, basket expansion and disciplined customer acquisition rather than discount-led growth.

Key Players

Investment Outlook

Digital health has strong secular tailwinds but must prove profitable unit economics amid regulatory flux. We favour platforms with repeat usage, cross-sell depth and disciplined acquisition over discount-led scale.

All figures are indicative and for information only - not investment advice or a recommendation. Market sizes, growth rates and financial metrics are hedged estimates that vary by source and period. Please consult your advisor before investing.